* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Test Info Sheet
Cell-free fetal DNA wikipedia , lookup
Protein moonlighting wikipedia , lookup
Epigenetics of diabetes Type 2 wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Gene desert wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Genome (book) wikipedia , lookup
Genome evolution wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Gene expression programming wikipedia , lookup
Gene therapy wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Gene expression profiling wikipedia , lookup
Gene nomenclature wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Oncogenomics wikipedia , lookup
Designer baby wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Neuronal ceroid lipofuscinosis wikipedia , lookup
Saethre–Chotzen syndrome wikipedia , lookup
Frameshift mutation wikipedia , lookup
GeneDx 207 Perry Parkway Gaithersburg, MD 20877 Phone: 301-519-2100 Fax: 301-519-2892 E-mail: [email protected] www.genedx.com Test Information Sheet HADHA and HADHB Gene Analysis in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD) /Mitochondrial Trifunctional Protein (MTP) Deficiency Mendelian Inheritance in Man Number: 609016 - LCHAD deficiency 600890 - HADHA gene 609015 - MTP deficiency 143450 - HADHB gene Clinical features: Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHAD deficiency) and Mitochondrial Trifunctional protein deficiency (MTP deficiency) also known as Trifunctional Protein (TFP) deficiency are disorders due to different defects in the MTP. MTP is an enzyme complex at the inner mitochondrial membrane with three enzymatic activities, long-chain 3hydroxyacyl-CoA dehydrogenase, 2-enoyl hydratase and 3-keto acyl-CoA thiolase activities. Both isolated LCHAD deficiency and MTP deficiency, which has deficiencies in all 3 enzyme activities, have overlapping clinical presentations. The variable presentation includes infantile hypoketotic hypoglycemia, vomiting, lethargy, hypotonia, and failure to thrive. Additional presentations are cardiomyopathy and cardiac conduction defects, severe liver disease, recurrent muscle cramps, seizures, coma or sudden death (SIDS)2. Peripheral neuromyopathy, and pigmentary retinopathy may develop at a later age.2 The high mortality rate for these disorders, estimated at 38%,4 is usually due to a Reye-like illness or fatal cardiomyopathy. Syndromes of maternal illness, HELLP (hypertension, elevated liver enzymes, low platelets) and AFLP (acute fatty liver of pregnancy) may occur in a pregnancy carrying a fetus with LCHAD/MTP deficiency.4 Inheritance pattern: Autosomal recessive Genetics and biochemical features: Mitochondrial trifunctional protein (MTP) catalyzes the last three steps of the β-oxidation of long-chain fatty acids. The enzyme complex is an octomer with 4 α and 4 β subunits. The α-subunit is encoded by the HADHA gene, while the βsubunit is encoded by the HADHB gene. Both genes are located on chromosome 2p23. Biochemically, isolated LCHAD deficiency refers to a reduction in the enzymatic activity of LCHAD, while MTP deficiency has a reduction in all three enzyme activities of the MTP.1 Most individuals with defects in MTP have isolated LCHAD deficiency that is due to mutations in the HADHA gene. Less commonly, individuals are identified with defects in all three MTP activities; these can be due to mutations in HADHA or HADHB. Even more rare, mutations in HADHB that cause isolated 3-keto acyl-CoA thiolase deficiency can be observed5. Mutations in these genes cause the accumulation of long-chain fatty acids and their metabolites. These metabolites are detectable in body fluids, and individuals with MTP and LCHAD deficiencies and although newborn screening for these disorders is done in many states, some cases of LCHAD/MTP deficiency are not detected by newborn screening. Confirmation of test findings can be done by molecular analysis of the HADHA and HADHB genes. The frequency of isolated LCHAD deficiency has not been determined, and MTP deficiency is even less common. Reasons for referral: 1. Diagnostic confirmation 2. Carrier testing 3. Genetic counseling 4. Prenatal diagnosis in at-risk pregnancies Test method: Mutation analysis of the HADHA gene is performed on genomic DNA from the submitted specimen. GeneDx offers the option of first testing for the common LCHAD deficiency HADHA mutation (c.1528 G->C) by restriction enzyme digestion. This mutation is found in approximately 60-87% of alleles.6 This test can be ordered alone or with reflex full sequence analysis of the HADHA gene if a homozygous mutation is not observed. For full sequencing the entire coding sequence and intron/exon boundaries of the 20-exon HADHA gene is analyzed by bi-directional sequencing. If two mutations are not identified in the HADHA gene, sequencing of the HADHB gene (exons 1-16) can be performed as a reflex test upon request; Information Sheet on LCHAD and MTP Page 1 of 2 © GeneDx 05/2013 alternatively, testing can be ordered simultaneously. Mutations first identified in a family are confirmed by repeat analysis using sequencing, restriction fragment analysis, or another appropriate method. Test sensitivity: In one study in patients with abnormal fibroblast LCHAD enzyme activity, 23/24 individuals were found to have two mutations the HADHA gene; one patient had only a single gene mutation identified.4 In another study of 52 French, MTPdeficient patients diagnosed by either increased plasma 3-hydroxy long-chain acylcarnitines, abnormal palmitate/myristate oxidation assays or reduced fibroblast LCHAD activities, two mutations in either the HADHA or HADHB genes were identified in all patients.6 Mutation spectrum: A common mutation in the HADHA gene (c.1528 G->C) in exon 15, accounts for approximately 87% of alleles in isolated LCHAD deficiency. 3,4 Mutations in HADHA are mostly missense, nonsense, small insertions/deletions and splice site changes. The majority of mutations identified in HADHB are missense, nonsense and small insertions/deletions. Specimen Requirements and Shipping/Handling: • Blood: A single tube with 1-5 mL whole blood in EDTA (1-2mL for infants). Ship overnight at ambient temperature, using a cool pack in hot weather. Specimens may be refrigerated for one week prior to shipping. • Buccal Brushes: Buccal brushes are not accepted on children under 6 months of age. For adults and children over 6 months, a GeneDx buccal kit (others not accepted) can be used as an alternative to blood. Submit by mail. • Prenatal Diagnosis: For prenatal testing for a known mutation in the HADHA or HADHB gene, please refer to the specimen requirements table on our website at: http://www.genedx.com/test-catalog/prenatal/. Ship specimen overnight at ambient temperature, using a cool pack in hot weather. Required Forms: Sample Submission (Requisition) Form – complete all pages Payment Options Form or Institutional Billing Instructions For test codes, prices, CPT codes, and turn-around-times, please refer to the “Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHAD deficiency)” or the “Mitochondrial Trifunctional protein deficiency (MTP deficiency)” page on our website: www.genedx.com References Cited: 1.) Tyni, T and Pihko, H. (1999) Acta Paediatr 88:237-245. 2.) Hintz, S. R., et al. (2002) Mol Genet Metab 75:120-127. 3.) den Boer MEJ, et al. (2002) Pediatrics 109:99-104. 4.) Ibdah, J.A., et al. (1999) N Engl J Med 340:1723-1731. 5) Das, A.M. et al., (2006) Clin Chem 52:530-534. 6. Boutron, et al., (2011) Mol Genet Metab 103:341-348. Information Sheet on LCHAD and MTP Page 2 of 2 © GeneDx 05/2013